Better Late than Early: FDG-PET Imaging in Metastatic Renal Cell Carcinoma

被引：8
|
作者：
Harrison, Michael R. [1 ,3 ]
George, Daniel J. [1 ,2 ,3 ]
机构：
[1] Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Surg, Div Urol, Durham, NC 27710 USA
[3] Duke Canc Inst, Durham, NC USA
来源：
CLINICAL CANCER RESEARCH | 2011年 / 17卷 / 18期
关键词：
POSITRON-EMISSION-TOMOGRAPHY; SUNITINIB;
D O I：
10.1158/1078-0432.CCR-11-1768
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Sunitinib treatment benefits patients with metastatic renal cell carcinoma (mRCC), but response duration can vary widely and resistance is not predicted by standard measures. [F-18]fluoro-2-deoxy-2-D-glucose positron emission tomography (FDG-PET) uptake is variable in mRCC, but changes in FDG-PET uptake may be useful in monitoring disease progression. Further work is needed to personalize treatment for patients with mRCC. Clin Cancer Res; 17(18); 5841-3. (C) 2011 AACR.
引用
收藏
页码：5841 / 5843
页数：3
相关论文
共 50 条
  • [1] Role of FDG-PET Scan in metastatic renal carcinoma
    Nimeh, T
    Albani, J
    Urbain, JL
    Bukowski, R
    Novick, A
    [J]. JOURNAL OF UROLOGY, 2002, 167 (04): : 195 - 195
  • [2] FDG PET/CT imaging of metastatic renal squamous cell carcinoma
    Aksoy, S. Y.
    Ozdemir, E.
    Kandemir, Z.
    Yildirim, N.
    Turkolmez, S.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2016, 35 (05): : 347 - 348
  • [3] FDG-PET detects thyroid cancer better than conventional imaging
    不详
    [J]. ONCOLOGY-NEW YORK, 2001, 15 (12): : 1601 - 1601
  • [4] FDG PET/CT as an imaging biomarker for patients with metastatic renal cell carcinoma
    Nakaigawa, N.
    Yao, M.
    Minamimoto, R.
    Namura, K.
    Makiyama, K.
    Ueno, D.
    Sakata, A.
    Kasuga, J.
    Inoue, T.
    Kubota, Y.
    [J]. EJC SUPPLEMENTS, 2010, 8 (07): : 195 - 196
  • [5] Comparison of Met-PET and FDG-PET for renal cell carcinoma
    Ito, S.
    Kato, K.
    Matsuo, K.
    Iwano, S.
    Naganawa, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S459 - S460
  • [6] Clinical role of early dynamic FDG-PET/CT for the evaluation of renal cell carcinoma
    Nakajima, Reiko
    Abe, Koichiro
    Kondo, Tsunenori
    Tanabe, Kazunari
    Sakai, Shuji
    [J]. EUROPEAN RADIOLOGY, 2016, 26 (06) : 1852 - 1862
  • [7] Clinical role of early dynamic FDG-PET/CT for the evaluation of renal cell carcinoma
    Reiko Nakajima
    Koichiro Abe
    Tsunenori Kondo
    Kazunari Tanabe
    Shuji Sakai
    [J]. European Radiology, 2016, 26 : 1852 - 1862
  • [8] Clinical value of FDG-PET for recurrent renal cell carcinoma
    Nakatani, Koya
    Nakamoto, Yuji
    Suga, Tsuyoshi
    Kawai, Kanae
    Ishizu, Koichi
    Higashi, Tatsuya
    Saga, T.
    Togashi, Kaori
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [9] FDG-PET Positivity and Overall Survival in Renal Cell Carcinoma
    Ferdinandus, Justin
    Maric, Ines
    Darr, Christopher
    Kesch, Claudia
    Bartel, Timo
    Fendler, Wolfgang Peter
    Gruenwald, Viktor
    [J]. JAMA NETWORK OPEN, 2022, 5 (11) : E2242289
  • [10] Imaging of metastatic clear cell carcinoma: FDG PET or PSMA PET?
    Saadat, S.
    Rhee, H.
    Tie, B.
    Wood, S.
    [J]. BJU INTERNATIONAL, 2017, 119 : 92 - 92
12345